Japanese media issued: Japanese medical equipment is stronger than China

Medical Network September 29th, the reference news network reported on September 28th according to the Japanese "Toyo Economic" weekly September 15 article, the size of China's medical equipment market in 2017 is about 21.35 billion US dollars (BMI Research Company data), continued Growth trend. But for Chinese companies, credibility has become a development barrier.

Japan’s second-largest medical device manufacturer Terumo’s head of China operations, chief executive officer Chai Qi Chongji pointed out that the Chinese doctor’s habit is that consumables use Chinese branded products, high-performance medical equipment uses foreign-branded products.

The Chinese government will be 'biological in 2015 medicine And high performance medical instruments 'listed as an important development area. To subsidize the Chinese brand of medical equipment, the Chinese government provides subsidies. Local public hospital purchase At the time of medical equipment, local governments allocate a certain percentage to Chinese manufacturers.

According to different medical levels, Chinese hospitals are divided into three levels, two levels and one level. Due to policy promotion, the introduction of high-performance medical equipment made in China by tertiary hospitals is increasing. However, there are cases where hospitals purchase medical equipment of Chinese brands. However, the actual use of high-performance medical equipment is a foreign brand.

The article said that doctors usually want to continue to choose the brand of medical equipment that has been used, which becomes China. enterprise Another obstacle faced. Olympus, Japan's largest manufacturer, entered the overseas market very early. It has mastered 70% of the world market share in the field of digestive system endoscopy, and it has also shown an overwhelming advantage in Japan.

Li Yuli, head of Olympus's Asia Pacific Business Planning Department, pointed out that China has introduced Olympus' digestive endoscopes. Olympus has the advantage of pioneers. The company was established in Shanghai, Beijing and Guangzhou. Medical Technology Training Center.

There are 26,000 physicians who master endoscopic operation technology in China and 30,000 in Japan. On the other hand, cancer patients such as gastric cancer in China are on the rise.

Lieutenant pointed out that China needs endoscopic technical guidance in the future, and the demand for endoscopes will also increase. The company's products are very popular in China, maintaining double-digit growth.

In terms of consumables, many Chinese companies are good at producing high value-added products such as syringes. Chai Qi pointed out that even if the shape is easy to imitate, the quality management techniques in actual production cannot be easily imitated. The favorable situation of Japanese companies seems to be able to maintain a segment. time.